[HTML][HTML] Rules of engagement: promoting academic-industry partnership in the era of digital pathology and artificial intelligence
L Pantanowitz, MM Bui, C Chauhan, E ElGabry… - Academic …, 2022 - Elsevier
Academic industry partnership (AIP) represents an important alliance between academic
researchers and industry that helps translate technology and complete the innovation cycle …
researchers and industry that helps translate technology and complete the innovation cycle …
Fifty years of radiopharmaceuticals
P Brugarolas, J Comstock, DW Dick… - Journal of nuclear …, 2020 - Soc Nuclear Med
To celebrate the 50th anniversary of the founding of the SNMMI Technologist Section in
1970, the Radiopharmaceutical Sciences Council board of directors is pleased to contribute …
1970, the Radiopharmaceutical Sciences Council board of directors is pleased to contribute …
New horizon of radiopharmaceuticals in management of neuroendocrine tumors
Neuroendocrine neoplasms are rare and heterogenous group of tumors with varying
degrees of clinical presentation and involvement of multiple organ systems in the body. In …
degrees of clinical presentation and involvement of multiple organ systems in the body. In …
Preparation of [68Ga]GaCl3 Using a Cyclotron
ME Rodnick, C Sollert, DC Parr, J Frigell… - … : Methods and Protocols, 2023 - Springer
Recent developments in 68Ga-radiopharmaceuticals, including a number of regulatory
approvals for clinical use, has created a hitherto unprecedented demand for 68Ga. Reliable …
approvals for clinical use, has created a hitherto unprecedented demand for 68Ga. Reliable …
Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of 68Ga DOTATOC as Assessed …
Purpose Gastroenteropancreatic neuroendocrine tumors (GEP NETs) are often associated
with high expression of somatostatin receptors (SSTRs) which allows for PET/CT imaging …
with high expression of somatostatin receptors (SSTRs) which allows for PET/CT imaging …
[HTML][HTML] Regulatory agencies and PET/CT imaging in the clinic
P Herscovitch - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review The regulatory steps necessary to bring new PET
radiopharmaceuticals to the clinic will be reviewed. The US Food and Drug Administration …
radiopharmaceuticals to the clinic will be reviewed. The US Food and Drug Administration …
Somatostatin receptor imaging PET in neuroendocrine neoplasm
CB Johnbeck, J Mortensen - PET clinics, 2021 - pet.theclinics.com
In the era of personalized medicine, neuroendocrine neoplasms (NENs) have paved the
way in nuclear medicine. The connection between diagnostics and consequent therapy …
way in nuclear medicine. The connection between diagnostics and consequent therapy …
Investigational new drug (IND) application
J Cedeno-Serna - Translational Sports Medicine, 2023 - Elsevier
The goal of translational biomedical research is to introduce a new experimental medicine
or device to market. The Food and Drug Administration (FDA) has created a protocol to …
or device to market. The Food and Drug Administration (FDA) has created a protocol to …
The Code of Contract: A Primer for Academia
V Maleppillil Vavachan - 2024 - nopr.niscpr.res.in
A contract is an enforceable agreement in conformity with contract law. The business
engagements of academia come under the purview of contract law, and it relies on the …
engagements of academia come under the purview of contract law, and it relies on the …
New drug application
MFH Abramuk - Translational Sports Medicine, 2023 - Elsevier
Every drug that is available on the market has to be approved by the Food and Drug
Administration (FDA). Drug information including results of clinical trials, results of animal …
Administration (FDA). Drug information including results of clinical trials, results of animal …